Literature DB >> 19962769

Unmasking of PML by HAART: unusual clinical features and the role of IRIS.

Navdeesh Sidhu1, J Allen McCutchan.   

Abstract

For patients with HIV/AIDS, highly active antiretroviral therapy (HAART) is currently the only effective therapy for progressive multifocal leukoencephalopathy (PML), a viral-induced demyelinating disease caused by polyomavirus JC. Immune reconstitution inflammatory syndrome (IRIS) following initiation of HAART can cause paradoxical clinical deterioration in patients with established PML. Because the onset of PML follows soon after initiation of HAART in some cases (unmasking), we investigated the role IRIS plays in unmasked PML. We reviewed records of 20 PML cases seen from 1997-2006 at the UCSD HIV primary care clinic. Eight cases presented with PML symptoms within 6months of initiating HAART (referred to hereafter as unmasked PML), six patients were diagnosed with PML before initiating HAART, and six were diagnosed more than 6months after starting HAART. Patients with unmasked PML constituted 40% of our series, had relatively long survival, and commonly (50%) had lesions exclusively in the posterior fossa, a localization not previously reported with such a high prevalence. Only 3 of the 8 patients with unmasked PML had IRIS reactions as evidenced by contrast enhancement around lesions on MRI, suggesting that IRIS is not necessary for the pathogenesis of this syndrome. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19962769      PMCID: PMC2825275          DOI: 10.1016/j.jneuroim.2009.11.013

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  37 in total

1.  The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

Authors:  P Cinque; C Pierotti; M G Viganò; A Bestetti; C Fausti; D Bertelli; A Lazzarin
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

3.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Authors:  Juan Berenguer; Pilar Miralles; Julio Arrizabalaga; Esteban Ribera; Fernando Dronda; Josu Baraia-Etxaburu; Pere Domingo; Manuel Márquez; Francisco J Rodriguez-Arrondo; Fernando Laguna; Rafael Rubio; José Lacruz Rodrigo; J Mallolas; Verónica de Miguel
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

4.  The uninvited guest: JC virus infection of neurons in PML.

Authors:  Kenneth L Tyler
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

Review 5.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  David Shitrit; Nirit Lev; Ariella Bar-Gil-Shitrit; Mordechai R Kramer
Journal:  Transpl Int       Date:  2004-12-23       Impact factor: 3.782

6.  Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.

Authors:  P Cinque; S Casari; D Bertelli
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

7.  Progressive multifocal leukoencephalopathy: clinical and radiographic features.

Authors:  L B Krupp; R B Lipton; M L Swerdlow; N E Leeds; J Llena
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

8.  Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.

Authors:  Aurélie Vendrely; Boris Bienvenu; Jacques Gasnault; Jean Baptiste Thiebault; Dominique Salmon; Françoise Gray
Journal:  Acta Neuropathol       Date:  2005-03-01       Impact factor: 17.088

Review 9.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

Review 10.  Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.

Authors:  Christian Manzardo; María Del Mar Ortega; Omar Sued; Felipe García; Asunción Moreno; José M Miró
Journal:  J Neurovirol       Date:  2005       Impact factor: 2.643

View more
  14 in total

Review 1.  An Overview of Human Immunodeficiency Virus Type 1-Associated Common Neurological Complications: Does Aging Pose a Challenge?

Authors:  Anantha Ram Nookala; Joy Mitra; Nitish S Chaudhari; Muralidhar L Hegde; Anil Kumar
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression.

Authors:  Michael W Ferenczy; Kory R Johnson; Shannon M Steinberg; Leslie J Marshall; Maria Chiara Monaco; Alexander M Beschloss; Peter N Jensen; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-20       Impact factor: 4.147

3.  Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection.

Authors:  Christine Fennema-Notestine; Ronald J Ellis; Sarah L Archibald; Terry L Jernigan; Scott L Letendre; Randy J Notestine; Michael J Taylor; Rebecca J Theilmann; Michelle D Julaton; David J Croteau; Tanya Wolfson; Robert K Heaton; Anthony C Gamst; Donald R Franklin; David B Clifford; Ann C Collier; Benjamin B Gelman; Christina Marra; Justin C McArthur; J Allen McCutchan; Susan Morgello; David M Simpson; Igor Grant
Journal:  J Neurovirol       Date:  2013-07-10       Impact factor: 2.643

Review 4.  The immune reconstitution inflammatory syndrome related to HIV co-infections: a review.

Authors:  D Huis in 't Veld; H-Y Sun; C-C Hung; R Colebunders
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-02       Impact factor: 3.267

5.  Reactivation of human polyomaviruses in immunocompromised states.

Authors:  Kari Wiedinger; Constantine Bitsaktsis; Sulie Chang
Journal:  J Neurovirol       Date:  2014-01-31       Impact factor: 2.643

Review 6.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 7.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogens.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

Review 8.  CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome.

Authors:  M J D Post; M M Thurnher; D B Clifford; A Nath; R G Gonzalez; R K Gupta; K K Post
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

9.  AIDS-related progressive multifocal leukoencephalopathy in a patient presenting with cerebellar ataxia.

Authors:  Chee Yik Chang
Journal:  Rev Soc Bras Med Trop       Date:  2021-06-02       Impact factor: 1.581

Review 10.  New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Anna Teresa Palamara; Lucia Nencioni; Valeria Pietropaolo
Journal:  Clin Dev Immunol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.